TD Cowen Has Lowered Expectations for CI&T (NYSE:CINT) Stock Price

CI&T (NYSE:CINT) had its target price cut by investment analysts at TD Cowen from $6.00 to $5.00 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. TD Cowen’s price target would indicate a potential upside of 43.06% from the company’s previous close.

Other analysts also recently issued reports about the stock. JPMorgan Chase & Co. reduced their price target on shares of CI&T from $6.00 to $5.00 and set an “overweight” rating for the company in a report on Wednesday. UBS Group dropped their price objective on shares of CI&T from $7.20 to $6.20 and set a “buy” rating on the stock in a report on Wednesday. Zacks Research lowered shares of CI&T from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 28th. Weiss Ratings cut shares of CI&T from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, June 29th. Finally, Wedbush downgraded CI&T from an “outperform” rating to a “neutral” rating and decreased their target price for the stock from $7.00 to $4.00 in a research report on Tuesday, July 21st. Seven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $6.08.

CI&T Stock Performance

NYSE CINT traded down $0.14 during trading on Wednesday, hitting $3.50. The company’s stock had a trading volume of 116,798 shares, compared to its average volume of 143,188. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 0.18. The firm has a 50 day moving average price of $3.53 and a 200 day moving average price of $4.24. The firm has a market cap of $470.35 million, a P/E ratio of 11.27 and a beta of 0.81. CI&T has a 52 week low of $3.03 and a 52 week high of $5.88.

CI&T (NYSE:CINT) last posted its quarterly earnings data on Tuesday, August 11th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.02). The business had revenue of $142.82 million during the quarter, compared to the consensus estimate of $140.05 million. CI&T had a net margin of 7.90% and a return on equity of 13.19%. Equities research analysts forecast that CI&T will post 0.32 earnings per share for the current fiscal year.

Institutional Investors Weigh In On CI&T

Institutional investors have recently bought and sold shares of the business. GMT Capital Corp acquired a new stake in CI&T during the fourth quarter valued at approximately $1,786,000. Royce & Associates LP lifted its position in shares of CI&T by 69.7% during the 4th quarter. Royce & Associates LP now owns 888,221 shares of the company’s stock worth $3,615,000 after buying an additional 364,696 shares during the period. BW Gestao de Investimentos Ltda. boosted its stake in CI&T by 9.2% in the 2nd quarter. BW Gestao de Investimentos Ltda. now owns 2,882,650 shares of the company’s stock valued at $17,209,000 after buying an additional 242,811 shares in the last quarter. Marshall Wace LLP boosted its stake in CI&T by 90.4% in the 2nd quarter. Marshall Wace LLP now owns 380,818 shares of the company’s stock valued at $2,273,000 after buying an additional 180,800 shares in the last quarter. Finally, XTX Topco Ltd bought a new stake in CI&T in the fourth quarter valued at $287,000. Institutional investors and hedge funds own 92.45% of the company’s stock.

CI&T News Roundup

Here are the key news stories impacting CI&T this week:

• Positive Sentiment: CI&T reported 21.9% organic revenue growth in the second quarter, supported by momentum across geographies, industries and its client base. Revenue totaled approximately $142.8 million, exceeding the $140.1 million consensus estimate. CI&T Reports 21.9% Organic Revenue Growth in 2Q26
• Positive Sentiment: UBS lowered its price target from $7.20 to $6.20 but maintained a Buy rating. The revised target still implies substantial potential upside from the recent share price, signaling that UBS views the selloff as excessive relative to CI&T’s growth prospects. UBS price target update
• Neutral Sentiment: Full-year revenue guidance of $565.5 million to $577.8 million brackets the $570.0 million analyst consensus, suggesting management’s outlook is broadly in line with expectations. The available update did not provide a specific third-quarter or full-year EPS figure. CI&T earnings report
• Negative Sentiment: Second-quarter adjusted earnings were $0.07 per share, below the $0.09-$0.10 consensus estimate and unchanged from the year-ago period. The earnings miss indicates that strong sales growth has not yet translated into equivalent bottom-line expansion. CI&T Q2 Earnings Miss Estimates
• Negative Sentiment: The UBS price-target reduction may pressure sentiment despite the retained Buy rating, particularly because CINT trades well below its 50-day and 200-day moving averages and remains close to its 12-month low.

About CI&T

CI&T Inc (NYSE:CINT) is a global digital solutions and technology services provider specializing in end-to-end digital transformation. The company partners with clients across industries such as financial services, retail, healthcare and technology to deliver tailored software products, agile development practices and customer-centric design. Its core offerings include digital strategy consulting, user experience and interface design, cloud-native application development, data engineering and full-cycle product lifecycle management.

Leveraging a proprietary agile framework, CI&T helps organizations accelerate time-to-market and improve operational efficiency through continuous delivery and DevOps automation.